Evaluation of The Effect of Nanocurcumin on Treatment of Tinnitus

Phase 3

Recruiting

• Conditions: Tinnitus; tinnitus.; H93.1

• Registration Number: IRCT20190916044785N1
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

Unilateral or Bilateral Subjective Tinnitus
Age Range: 18-65 Year
Patients do not have Pregnancy and Breastfeeding
Patients do not have Acute or Chronic Ear Infection
Patients do not have Rheumatologic Diseases, Vasculitis, Acoustic Neuroma, Known Neurological Disorders and Ear Surgery
Patients not taking Immunosuppressants such as Interferons, Corticosteroids, Anticonvulsants and Sedatives before starting the study

Exclusion Criteria

Patients who do not willing to enter the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tinnitus Handicap Inventory. Timepoint: Before and after 21 days of Medicine Consumption. Method of measurement: Tinitus Matching Test.